Nabriva Therapeutics Stock Forecast - Accumulation Distribution

NBRVDelisted Stock  USD 1.62  0.01  0.61%   
Nabriva Stock Forecast is based on your current time horizon.
  
Nabriva Therapeutics AG has current Accumulation Distribution of 0.0061. The accumulation distribution (A/D) indicator shows the degree to which Nabriva Therapeutics is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Nabriva Therapeutics AG to determine if accumulation or reduction is taking place in the market. This value is adjusted by Nabriva Therapeutics trading volume to give more weight to distributions with higher volume over lower volume.
Check Nabriva Therapeutics VolatilityBacktest Nabriva TherapeuticsInformation Ratio  

Nabriva Therapeutics Trading Date Momentum

On December 02 2024 Nabriva Therapeutics AG was traded for  1.62  at the closing time. The top price for the day was 1.63  and the lowest listed price was  1.62 . There was no trading activity during the period 0.0. Lack of trading volume on December 2, 2024 did not cause price change. The trading delta at closing time against the current closing price is 0.62% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Nabriva Therapeutics to competition

Nabriva Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Nabriva Therapeutics stock to make a market-neutral strategy. Peer analysis of Nabriva Therapeutics could also be used in its relative valuation, which is a method of valuing Nabriva Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Nabriva Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Nabriva Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nabriva Therapeutics shares will generate the highest return on investment. By undertsting and applying Nabriva Therapeutics stock market strength indicators, traders can identify Nabriva Therapeutics AG entry and exit signals to maximize returns.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Consideration for investing in Nabriva Stock

If you are still planning to invest in Nabriva Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nabriva Therapeutics' history and understand the potential risks before investing.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
CEOs Directory
Screen CEOs from public companies around the world
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Bonds Directory
Find actively traded corporate debentures issued by US companies
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world